Meril

Executive Summary

Meril Life Sciences is a leading Indian medical-device company specializing in orthopedics, cardiovascular, and wound-care products. Founded in 1995 and headquartered in Mumbai, the company leverages proprietary polymer-metal hybrid technologies and advanced hydrogel formulations to deliver cost-effective solutions for joint replacement, coronary interventions, and chronic wound management. With a primary focus on emerging markets, Meril has established a strong presence by addressing the affordability and accessibility gaps in healthcare. Backed by $150 million in funding, the company operates at a commercial stage with over 1,000 employees and continues to expand its product portfolio. Its innovative approach and strategic positioning in high-growth regions make it a compelling player in the global med-tech landscape.

Upcoming Catalysts (preview)

• Q3 2026Regulatory approval for next-generation orthopedic implant in emerging markets80% success
• Q3 2026Expansion into Southeast Asian markets via distributor partnerships70% success
• TBDLaunch of advanced wound-care hydrogel product line in India85% success